Sign in

CIK 0001534248

  • Non-accelerated filer
  • Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
EIN
813676773
Phone
+972 773310156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,516
in 1 filing

Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohen Neil Harris −$7K Director sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-05-29 Mor George Adi Chief Executive Officer Purchase −4,878 $2.05 $10K 134,205
2026-05-29 Mor George Adi Chief Executive Officer Purchase −4,926 $2.08 $10K 139,131
2026-05-29 Mor George Adi Chief Executive Officer Other disposition −31,712 31,712
2026-05-29 Mor George Adi Chief Executive Officer Other disposition −18,750 18,750
2023-01-03 Mor George Adi Chief Scientific Officer Sale −7,700 $5.03 $39K 317,075
2023-01-03 Mor George Adi Chief Scientific Officer Sale −6,100 $5.03 $31K 251,147
2022-11-16 Mor George Adi Chief Scientific Officer Sale −324,775 $2.08 $677K 324,775
2022-11-16 Mor George Adi Chief Scientific Officer Sale −257,248 $2.08 $536K 257,247
2018-03-15 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +131,698 131,698
2018-03-15 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +131,698 131,698
2016-10-28 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +33,725 33,725
2016-10-28 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +33,725 33,725

Page 1 of 1 · 12 trades